# OnCo record peripheral-neuropathy (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/peripheral-neuropathy/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "peripheral-neuropathy" ;
  schema:name "Peripheral neuropathy (chemotherapy-induced)"@en ;
  schema:alternateName "neuropathy"@en, "peripheral neuropathy"@en, "chemotherapy-induced peripheral neuropathy"@en, "CIPN"@en, "sensory neuropathy"@en, "motor neuropathy"@en, "neuropathic"@en, "numbness"@en, "tingling"@en, "paraesthesia"@en, "paresthesia"@en, "cold-induced neuropathy"@en, "cumulative neuropathy"@en, "neurotoxicity"@en, "neurotoxic"@en, "ototoxicity"@en, "hearing loss"@en, "tinnitus"@en, "neuropathies"@en ;
  schema:description "Nerve damage from chemotherapy that causes numbness, tingling and pain in the hands and feet, and sometimes weakness or hearing loss. It builds up with each dose, can be permanent, and is the main reason oxaliplatin, taxanes and vincristine have to be stopped or reduced."@en ;
  schema:url <https://onco.cc/terms/peripheral-neuropathy/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Chemotherapy-induced_peripheral_neuropathy> ;
  schema:citation <https://en.wikipedia.org/wiki/Chemotherapy-induced_peripheral_neuropathy>, <https://www.macmillan.org.uk/cancer-information-and-support/impacts-of-cancer/peripheral-neuropathy>, <https://www.nhs.uk/conditions/peripheral-neuropathy/>, <https://doi.org/10.1200/JCO.20.01399>, <https://www.pancreaticcancer.org.uk/information-and-support/treatments-for-pancreatic-cancer/chemotherapy/side-effects-of-chemotherapy/>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/folfirinox>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/oxaliplatin>, <https://www.bowelcanceruk.org.uk/about-bowel-cancer/living-with-and-beyond-bowel-cancer/long-term-and-late-side-effects/>, <https://www.nice.org.uk/guidance/ng151/chapter/Recommendations> ;
  onco:related <https://onco.cc/terms/taxane/>, <https://onco.cc/terms/folfox-family/>, <https://onco.cc/terms/dose-modification/>, <https://onco.cc/terms/late-effects/> ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/rejuvenation/> ;
  onco:drugs <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/docetaxel/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/bortezomib/>, <https://onco.cc/drugs/brentuximab-vedotin/>, <https://onco.cc/drugs/sodium-thiosulfate/> .